- 24 June 2022SV NewsPaul LaViolette recently participated in a 1:1 keynote with Shockwave Medical CEO Doug Godshall @ The Medtech MVP Conference in Minneapolis.
- 25 March 2022Portfolio NewsPodimetrics Secures $45M for SmartMat to Prevent Diabetic Amputations in High-Risk Patients
- 2 March 2022Portfolio NewsAlpheus Medical Announces Formation of World-Class Scientific Advisory Board (SAB) to Support Development of Novel Treatment for Brain Cancer
- 9 February 2022SV NewsNeurovascular company Perfuze raises €22.5M ($25M) Series A for a new stroke treament
- 5 January 2022Portfolio NewsEndotronix Announces FDA Approval for PROACTIVE-HF Pivotal Trial Design Change to Single-Arm Study
- 4 January 2022Portfolio NewsCarePredict, Inc. is mentioned in The Wall Street Journal as a top trend to watch in CES2022
- 14 December 2021Portfolio NewsZerigo Health Expands Board of Directors
- 17 November 2021Portfolio NewsAlpheus Medical Closes $16M In Series A Financing For Novel Glioma Brain Cancer Treatment
- 4 November 2021SV NewsVibrato Medical announced that Paul A. LaViolette has been appointed to its board of directors.
- 21 October 2021Portfolio NewsZerigo Health Raises $43 Million in Series B Funding to Drive Adoption of the Industry’s Only Connected Light Therapy Solution to Treat Chronic Skin Conditions
- Video3 August 2021SV NewsPaul LaViolette describes SV's investment focus
- 15 December 2020SV NewsSV Health Investors Promotes Greg Madden to Managing Partner